HCC70 Orthotopic Model

Synonyms: HCC-70

HCC70 is a cell line derived from human triple-negative breast cancer (TNBC), a subtype characterized by the absence of estrogen receptors, progesterone receptors, and HER2 expression. This cell line provides a critical model for researching TNBC, one of the most aggressive and challenging breast cancer subtypes to treat. HCC70 maintains essential molecular and genetic markers found in TNBC patients, validating its use for in-depth in vitro and in vivo studies. Its behavior, which encompasses tumor growth, metastatic tendencies, and unique resistance mechanisms, mirrors the clinical attributes of TNBC. Researchers worldwide lean on HCC70 to delve into the intricacies of TNBC and to explore and refine innovative treatment options.

Model Details

Cancer Type: Breast Cancer
Model Name: HCC70
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Paclitaxel)

HCC70 Growth curves: Response to Paclitaxel dosed QW

Growth of orthotopic (MFP) HCC70 in Nu/Nu mice (n=6)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content